Elix, Inc. (CEO: Shinya Yuki / HQ: Tokyo, hereinafter “Elix”), an AI drug discovery company with the mission of “Rethinking Drug Discovery”, today announced …
Elix and PRISM BioLab Join Forces to Accelerate AI-Driven Drug Discovery for Challenging Protein-Protein Interaction Targets
